Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Synthesis and biological evaluation of PSMA-targeting paclitaxel conjugates.
Machulkin AE, Skvortsov DA, Ivanenkov YA, Ber AP, Kavalchuk MV, Aladinskaya AV, Uspenskaya AA, Shafikov RR, Plotnikova EA, Yakubovskaya RI, Nimenko EA, Zyk NU, Beloglazkina EK, Zyk NV, Koteliansky VE, Majouga AG. Machulkin AE, et al. Among authors: uspenskaya aa. Bioorg Med Chem Lett. 2019 Aug 15;29(16):2229-2235. doi: 10.1016/j.bmcl.2019.06.035. Epub 2019 Jun 20. Bioorg Med Chem Lett. 2019. PMID: 31248772
Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA.
Ivanenkov YA, Machulkin AE, Garanina AS, Skvortsov DA, Uspenskaya AA, Deyneka EV, Trofimenko AV, Beloglazkina EK, Zyk NV, Koteliansky VE, Bezrukov DS, Aladinskaya AV, Vorobyeva NS, Puchinina MM, Riabykh GK, Sofronova AA, Malyshev AS, Majouga AG. Ivanenkov YA, et al. Among authors: uspenskaya aa. Bioorg Med Chem Lett. 2019 May 15;29(10):1246-1255. doi: 10.1016/j.bmcl.2019.01.040. Epub 2019 Feb 1. Bioorg Med Chem Lett. 2019. PMID: 30904185
Corrigendum to 'Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA' [Bioor. Med. Chem. Lett. 29/10 (2019) 1246-1255].
Ivanenkov YA, Machulkin AE, Garanina AS, Skvortsov DA, Uspenskaya AA, Deyneka EV, Trofimenko AV, Beloglazkina EK, Zyk NV, Koteliansky VE, Bezrukov DS, Aladinskaya AV, Vorobyeva NS, Puchinina MM, Ryabykh GK, Sofronova AA, Malyshev AS, Majouga AG. Ivanenkov YA, et al. Among authors: uspenskaya aa. Bioorg Med Chem Lett. 2019 Jul 1;29(13):1688. doi: 10.1016/j.bmcl.2019.04.038. Epub 2019 May 2. Bioorg Med Chem Lett. 2019. PMID: 31056242 No abstract available.
Polypeptide-Based Molecular Platform and Its Docetaxel/Sulfo-Cy5-Containing Conjugate for Targeted Delivery to Prostate Specific Membrane Antigen.
Petrov SA, Machulkin AE, Uspenskaya AA, Zyk NY, Nimenko EA, Garanina AS, Petrov RA, Polshakov VI, Grishin YK, Roznyatovsky VA, Zyk NV, Majouga AG, Beloglazkina EK. Petrov SA, et al. Among authors: uspenskaya aa. Molecules. 2020 Dec 8;25(24):5784. doi: 10.3390/molecules25245784. Molecules. 2020. PMID: 33302417 Free PMC article.
Synthesis and Biological Evaluation of PSMA Ligands with Aromatic Residues and Fluorescent Conjugates Based on Them.
Machulkin AE, Shafikov RR, Uspenskaya AA, Petrov SA, Ber AP, Skvortsov DA, Nimenko EA, Zyk NU, Smirnova GB, Pokrovsky VS, Abakumov MA, Saltykova IV, Akhmirov RT, Garanina AS, Polshakov VI, Saveliev OY, Ivanenkov YA, Aladinskaya AV, Finko AV, Yamansarov EU, Krasnovskaya OO, Erofeev AS, Gorelkin PV, Dontsova OA, Beloglazkina EK, Zyk NV, Khazanova ES, Majouga AG. Machulkin AE, et al. Among authors: uspenskaya aa. J Med Chem. 2021 Apr 22;64(8):4532-4552. doi: 10.1021/acs.jmedchem.0c01935. Epub 2021 Apr 6. J Med Chem. 2021. PMID: 33822606
The Importance of Linkers in the Structure of PSMA Ligands.
Uspenskaya AA, Nimenko EA, Machulkin AE, Beloglazkina EK, Majouga AG. Uspenskaya AA, et al. Curr Med Chem. 2022;29(2):268-298. doi: 10.2174/0929867328666210804092200. Curr Med Chem. 2022. PMID: 34348608 Review.
PSMA-targeted small-molecule docetaxel conjugate: Synthesis and preclinical evaluation.
Machulkin AE, Uspenskaya AA, Zyk NY, Nimenko EA, Ber AP, Petrov SA, Shafikov RR, Skvortsov DA, Smirnova GB, Borisova YA, Pokrovsky VS, Kolmogorov VS, Vaneev AN, Ivanenkov YA, Khudyakov AD, Kovalev SV, Erofeev AS, Gorelkin PV, Beloglazkina EK, Zyk NV, Khazanova ES, Majouga AG. Machulkin AE, et al. Among authors: uspenskaya aa. Eur J Med Chem. 2022 Jan 5;227:113936. doi: 10.1016/j.ejmech.2021.113936. Epub 2021 Oct 23. Eur J Med Chem. 2022. PMID: 34717125
Synthesis, Characterization, and Preclinical Evaluation of a Small-Molecule Prostate-Specific Membrane Antigen-Targeted Monomethyl Auristatin E Conjugate.
Machulkin AE, Uspenskaya AA, Zyk NU, Nimenko EA, Ber AP, Petrov SA, Polshakov VI, Shafikov RR, Skvortsov DA, Plotnikova EA, Pankratov AA, Smirnova GB, Borisova YA, Pokrovsky VS, Kolmogorov VS, Vaneev AN, Khudyakov AD, Chepikova OE, Kovalev S, Zamyatnin AA Jr, Erofeev A, Gorelkin P, Beloglazkina EK, Zyk NV, Khazanova ES, Majouga AG. Machulkin AE, et al. Among authors: uspenskaya aa. J Med Chem. 2021 Dec 9;64(23):17123-17145. doi: 10.1021/acs.jmedchem.1c01157. Epub 2021 Nov 19. J Med Chem. 2021. PMID: 34797052
Synthesis and initial in vitro evaluation of PSMA-targeting ligands with a modified aromatic moiety at the lysine ε-nitrogen atom.
Zyk NY, Ber AP, Nimenko EA, Shafikov RR, Evteev SA, Petrov SA, Uspenskaya AA, Dashkova NS, Ivanenkov YA, Skvortsov DA, Beloglazkina EK, Majouga AG, Machulkin AE. Zyk NY, et al. Among authors: uspenskaya aa. Bioorg Med Chem Lett. 2022 Sep 1;71:128840. doi: 10.1016/j.bmcl.2022.128840. Epub 2022 May 31. Bioorg Med Chem Lett. 2022. PMID: 35661685
11 results